Back
Axsome Therapeutics 10K Form
Sell
47
AXSM
Axsome Therapeutics
Last Price:
93.17
Seasonality Move:
12.35%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive AXSM News And Ratings
See the #1 stock for the next 7 days that we like better than AXSM
AXSM Financial Statistics
Sales & Book Value
Annual Sales: | $270.6M |
---|---|
Cash Flow: | $-30.16M |
Price / Cash Flow: | 0 |
Annual Sales: | $2.15 |
Price / Book: | 43.46 |
Profitability
EPS (TTM): | -6.51000 |
---|---|
Net Income (TTM): | $-308.55M |
Gross Margin: | $244.54M |
Return on Equity: | -156.44% |
Return on Assets: | -53.3% |
Axsome Therapeutics Earnings Forecast
Key Axsome Therapeutics Financial Ratios
- The Gross Profit Margin over the past 4 years for AXSM is 90.37%.
- The Selling, General & Administrative Expenses for AXSM have been equal to 119.41% of Gross Profit Margin.
- The Research & Development expenses have been 36.20% of Revenue.
- The Interest Expense is -2.70% of Operating Income.
- The Net Earning history of AXSM is -88.41% of Total Revenues.
- Per Share Earnings over the last 11 years have been positive in 2 years.
Axsome Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Pharmaceuticals |
Sector: | Health Care |
Current Symbol: | AXSM |
CUSIP: | 05464T |
Website: | axsome.com |
Debt
Debt-to-Equity Ratio: | 1.74 |
---|---|
Current Ratio: | 2.48 |
Quick Ratio: | 2.34 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
AXSM Technical Analysis vs Fundamental Analysis
Sell
47
Axsome Therapeutics (AXSM)
is a Sell
Is Axsome Therapeutics a Buy or a Sell?
-
Axsome Therapeutics stock is rated a Sell
The current Axsome Therapeutics [AXSM] share price is $93.13. The Score for AXSM is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.